DB: Combining an existing drug with chemotherapy can suppress an aggressive type of breast cancer’s resurgence, a study published Tuesday found.
The study, published in The New England Journal of Medicine, found that treating patients with both Keytruda, an immunotherapy drug, and chemotherapy prior to surgery reduced the chances of disease recurrence for early triple-negative breast cancer by 37 percent when compared with patients treated solely with chemotherapy.
Lead researcher Peter Schmid, a professor at Queen Mary University of London, said, “The estimates are that, just in the US where this treatment was recently approved by the Food and Drug Administration, this new treatment may save as many as 10,000 lives per year.”
VT Editors is a General Posting account managed by Jim W. Dean and Gordon Duff. All content herein is owned and copyrighted by Jim W. Dean and Gordon Duff
Due to the nature of independent content, VT cannot guarantee content validity.
We ask you to Read Our Content Policy
so a clear comprehension of VT's independent non-censored media is understood and given its proper place in the world of news, opinion and media.
All content is owned by author exclusively. Expressed opinions are NOT necessarily the views of VT, other authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.
- Read Full Policy Notice
- Comment Policy